 The purpose of this clinical trial is to collect safety and effectiveness data concerning the A-MAVTM Anterior Motion Segment Replacement device as a method of treating patients with lumbar degenerative disc disease at one level from L4-S1. Overall success will be the primary clinical endpoint. 